Number of Shares
64,445.00
Current Holdings Value*
$8.55 Mil
% of Portfolio
1.78%
Total Estimate Gain
$2.56 Mil
% of Total Estimate Gain
21.82%

Providence Capital Advisors, LLC's Abbott Laboratories Holding Summary

As of 2025-03-31, Providence Capital Advisors, LLC held 64,445.00 shares of Abbott Laboratories(ABT), totaling $8.55 Mil. This investment constitutes 1.78% of their stock portfolio, and Providence Capital Advisors, LLC now holds 0% of the outstanding Abbott Laboratories(ABT) stock.

The initial trade took place in 2018Q4. And since then Providence Capital Advisors, LLC has made 20 purchases of ABT, at an average price of $98.56, for a total of 118,799.00 shares. In addition, there have been 6 sales at an average price of $113.46 for 54,354.00 shares. Based on historical transaction data and ABT's current price of $125.64, Providence Capital Advisors, LLC's estimated gain on his ABT holdings is $2.56 Mil, reflecting a 21.82% gain to date.

Providence Capital Advisors, LLC ABT ($125.64) Holding Chart

Providence Capital Advisors, LLC ABT ($125.64) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1